Despite having only a limited number of Chinese samples (n=12 pairs), examination of the TCGA database revealed that ADAM10 expression reached its highest level in Stage III non-small cell lung cancer (NSCLC) patients. This evidence concerns the gene ADAM10 and non-small cell lung carcinoma.